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Transmissable venereal tumour (TVT) is a tumour transplanted by physical contact between dogs. 
Lesions typically affect the genitalia. TVT is not considered enzootic in the United Kingdom (UK), with 
cases seen in imported dogs. We sought to determine the patient characteristics, temporal and spatial 
distribution, and country of origin of affected dogs in the UK. 
 
Methods 
Electronic pathology records (EPRs) from four UK veterinary diagnostic laboratories collected between 
2010 and 2019 were searched for the terms ‘venereal’ or ‘TVT’. Reports were reviewed for statements 
confirming a TVT and descriptive statistics collated.  
 
Results 
Of 182 EPRs matching the search terms, a diagnosis of TVT was confirmed in 71. Country of origin 
was noted in 36 cases (50.7%) with Romania being the most common (n=29). Cases were reported in 
each UK constituent country, with the majority being in England (64, 90.1%). The incidence of TVT 
diagnosis increased over the last decade (z=2.78, P=0.005).  
 
Conclusions/Discussion 
The incidence of TVT diagnosed in the UK is increasing. The majority of cases were known to have 
been imported. Autochthonous transmission cannot be excluded due to study design. Vets are 





Canine transmissible venereal tumour (TVT) is an infectious tumour of dogs (1–4). TVT is transmitted 
between dogs by direct transplantation of living tumour cells from one dog to another, typically during 
mating when abraded mucosa is exposed to the tumour of an infected dog (4). Transmission via licking, 
sniffing and parturition have also been reported, thus TVT represents an infectious cell line that is 
transmissible as a naturally occurring allograft (4–7). 
 
TVT is the oldest and most widely disseminated cancer in the natural world, with evidence of emergence 
approximately 11,000 years ago (8,9). TVT can be transmitted only via living tumour cells – not killed 
cells or cellular filtrates. This demonstrates the transmissible nature of the cells themselves (4,6,10). 
The patterns of genetic identity found in tumours located in different continents is consistent with a 
single clonal origin (6,8). Normal canine cells have 78 chromosomes while TVT cells have a vastly 
rearranged karyotype containing 58-59 chromosomes (11,12). Though TVT is classified as a round cell 
tumour hypothesised as being of histiocytic origin (13,14), its original cell of origin is not definitively 
known. 
 
Lesions typically affect the external genitalia of dogs of either sex but can also be present in other 
locations such as cutaneous, nasal or oral lesions (15–17). The tumour can range in size from a small 
nodule to a large mass and is typically cauliflower-like, firm but friable and frequently ulcerated or 
inflamed. Local invasion is common, but distant metastasis is rare and usually only occurs in 
immunocompromised dogs or puppies (5).  
 
As an allograft, TVT should be readily cleared by an immunocompetent host, as occurs in organ 
transplant without immunosuppression. When an immunocompetent, naïve adult dog is exposed to an 
infectious transplant of TVT cells, a tumour growth phase of 2-6 months occurs. During this period, very 
low levels of major histocompatibility complex (MHC) expression likely contribute to the tumour’s ability 
to evade immune surveillance (18–21). After the growth period, whilst some TVTs stabilise in size, most 
regress. The factors that lead to the initial implantation of the tumour and the switch between the growth 
and stabilisation/regression phases are incompletely understood, but the latter phase is associated with 
increased tumour MHC expression, and a parallel increased immune response against the tumour (18–
21). These changes in MHC expression are hypothesised to be the most significant contributor to the 
tumour’s natural history, and as a consequence, TVT is rarely fatal, but is perpetuated within the 
population by tumour transmission during the period of immune evasion (6).  
 
Whilst spontaneous regression has been reported in experimental settings (22) the course of naturally 
acquired TVT is not well documented and therefore it should not be assumed that spontaneous 
regression will occur. Consequently, to ensure resolution, reduce associated welfare issues and prevent 
further transmission most cases in pet animals are treated. Weekly systemic treatments with vincristine 
are most commonly used, and typically lead to regression and clinical cure in 3-5 weeks (23–26). 
Radiotherapy has also been used in refractory cases, with good responses reported (27).  
 
Worldwide, TVT is a common disease and has been reported in all inhabited continents (28,29). It is 
typically associated with stray or free roaming dog populations in which uncontrolled mating occurs 
(28). TVT is more common in tropical and sub-tropical regions and is uncommon in North America and 
North and Central Europe, largely due to control of stray dog populations (28). In the United Kingdom 
(UK), TVT is not considered enzootic, but occasional cases have been anecdotally reported in imported 
dogs.  
 
A huge amount of epidemiological information is held within the pathology records of diagnostic 
laboratories pertaining to signalment and diagnosis of neoplasia. They are one of the possible sources 
of information for tumour registries. Tumour registries are important tools in the epidemiological 
monitoring of cancer; they have been used to assess and monitor incidence of cancer and determine 
effectiveness of public health interventions in reducing cancer rates (30,31). The Small Animal 
Veterinary Surveillance Network (SAVSNET) collects both patient clinical records from veterinary 
practices and EPRs from diagnostic laboratories, using them for a variety of purposes including 
monitoring for infectious diseases (32,33) and surveillance (34). The diagnostic laboratory data includes 
EPRs from the majority of the UK’s commercial diagnostic laboratories and therefore represents a rich 
and novel source of information for evaluating the occurrence of TVT in the UK setting.  
 
Given the lack of knowledge of TVT within the UK, and the (albeit small) potential for this condition to 
become established and endemic in the UK from dogs imported or returning from overseas, the aim of 
this study was to describe TVT cases diagnosed in the UK including the incidence, neuter status, 
geospatial distribution and country of origin of affected dogs. 
Materials and Methods 
This is a retrospective cohort study. The dataset was developed by searching datasets of cytology and 
histopathology submissions made to four comercial laboratories in the UK between the 29th September 
2010 and 30th October 2019 (inclusive). This data had been collated anonymously as part of the 
laboratories’ voluntary participation in SAVSNET, which has been ethically approved by the University 
of Liverpool research ethics committee (RETH0000964). 
 
In order to identify possible cases, a digital search term was developed using the phrases ‘venereal’ or 
‘TVT’. The EPRs identifed were manually evaluated by a single domain expert (DG). The inclusion 
criteria were dogs who had been diagnosed with TVT on the basis of a cytology and/or histology sample. 
Cases were excluded if the report was about any other species aside from dogs, the results did not 
pertain to a histology or cytology sample, a diagnosis other than TVT was reached or the pathologist 
suspected TVT, but suggested further diagnostic tests such as immunohistochemistry were required to 
confirm the diagnosis, and there was no recorded evidence from the EPR that these were performed.  
 
Patient data was collated for cases, including signalment (age, breed, sex, neuter status) when 
available, date of submission (this date was chosen over date of diagnosis as the latter was not always 
available), lesion location, whether cytology, histology or both were performed, geographic location. 
Information pertaining to travel status or country of origin (if recorded) were also included.  
 
Data was exported to a Microsoft Excel spreadsheet, cleaned by harmonising variable terms (eg dog 
and canine), duplicates removed using the laboratory sample accession number (e.g. dogs that had 
two submissions under an identical lab number typically if there was both a cytology and histology 
sample), and descriptive statistics performed. A Mann-Kendall trend test was performed using the 
‘trend’ package in R (version 4.0.3) to assess incidence of TVT cases over time per 10,000 cytology or 
histology submissions submitted for any clinical reason, over the aforementioned time period. A map 
documenting diagnoses of TVT during the study period by UK administrative area was created using 
the Microsoft Excel for Mac (Version 16.45) ‘Filled Map’ chart. A Mann-Kendall trend test was performed 
to address the possibility that increasing case numbers may be an artefact caused by an overall 
increasing number of laboratory submissions or the increasing market share of the participating 
laboratories. The yearly incidence of TVT cases per 10,000 (with 95% confidence intervals) cytology or 
histology submissions to laboratories over the same time period was assessed. 95% confidence 
intervals surrounding annual proportional incidence in TVT diagnosis compared to all histological and 
cytological submissions being submitted for that year were calculated using the exact interval method 
(also known as the Clopper-Pearson interval) available via the 'prevalence' R package(35). A p value 
of <0.05 was considered significant. 
Results 
The initial case population comprised 182 cases, comprising 81 cytology and 101 histology samples. 
Of these, 45 reports were excluded because although the pathology was consistent with a round cell 
tumour, the exact diagnosis as recorded in the EPR was not definitive. In these reports, further testing 
had often been recommended without recorded linked evidence of it being performed, or a final 
diagnosis was not reached. A further 56 reports were excluded as they were diagnosed with another 
condition (Supplementary table 1), and 10 were excluded as the samples were non-diagnostic.  
 
Seventy-one cases met the inclusion criteria, of which 13 were diagnosed by cytology (18%) and 58 
(81%) by histology. Only 5 included cases had both a cytology and histology submission and there were 
no cases where these results were contradictory. The majority of affected dogs were mixed breed 
(n=47, 66%). Other breeds represented included Border Collie (n=2), Staffordshire bull terrier (n=2), 
Labrador retreiver (n=1) golden retreiver (n=1), Chihuahua (n=1), English setter (n=1), Newfoundland 
(n=1) and old English sheepdog (n=1). The breed of 14 dogs was not recorded. Twenty-five (35%) were 
female neutered, 27 (38%) male neutered, eight (11%) were entire male, and eight (11%) were entire 
female.Sex was unknown in three dogs. Age data was not present for a lot of records which precluded 
meaningful analysis.  
 
The described lesions were predominantly assocated with the genitalia. In the 33 female dogs, 23 
(69.7%) were reported as affecting the vagina, and seven (21.2%) the vulva. In the 35 male dogs, 18 
(51.4%) were located on the penis and 14 (40.0%) on the prepuce. The majority of lesions were on the 
genitalia regardless of neuter status. Other less common locations included lip, the perineum and a 
lymph node (one case each). Lesion location was not recorded in six cases. The majority of cases 
(47/71, 66%) presented with a single lesion. Multiple lesions were reported in 8 cases (11%) including 
the case where TVT was diagnosed in the lymph node. The history from the submitting vet in that case 
described ‘multiple skin lesions’ but these were not sampled. It would be suspected that at least some 
of those lesions were TVT as a primary lymph node TVT would be extremely unusual. Number of lesions 
was not reported in 16 cases (22%). As this data was obtained from the pathology submission form 
(rather than direct examination of the animal) the possibility that some cases classified as having a 
single lesion actually had multiple lesions cannot be entirely excluded.  
 
Import status and country of origin was reported in 36 of the 71 cases (50.7%), of which the majority 
were reported to be from Romania (29 of 36, 81.0%). Other countries of origin included Serbia (2), 
Spain (1), China (1), Greece (1) and Gambia (1). One further dog was listed as imported, but a country 
of origin was not stated.  
 
Within the UK, based on the postcode of the submitting veterinary practice, the majority of cases were 
seen in England (65 of 71, 91.5%). Four cases were reported from Scotland and one each from 
Northern Ireland and Wales. The location of one submitting practice was unknown. Cases were seen 
across England (Figure 1), although the highest proportion were in the south, with 26 of 71 in the South 
East, and seven in the South West region. Twelve were located in the East Midlands and three in the 
West Midlands. Six cases were seen in the East of England and three in Yorkshire and the Humber. In 




Figure 1: Veterinary practice site distribution of TVT cases across the UK. Deeper shades of blue 
indicates more cases. Grey areas had no recorded cases. There may be some bias in this figure from 
underlying population size and laboratory demographics 
 
While the total number of cases remained low, the frequency with which TVT was diagnosed increased 




Figure 2: Number of TVT diagnoses by year across the participating UK laboratories 
 
The Mann-Kendall  trend test was was performed to assess the rate of TVT cases per 10,000 (with 
95% confidence intervals) cytology or histology submissions to laboratories over the same time period 
(Figure 3). This showed a significant upward trend (z=2.78, P=0.005), which is consistent with an 

























Figure 3: Yearly incidence of TVT diagnosis per 10 000 cytology and histology submissions (blue line) 
with 95% confidence intervals (blue shading) 
 
 Discussion 
TVT is an unusual infectious tumour of dogs that is transmitted by physical transplantation. TVT is 
primarily transmitted during mating activity. There are various historical reports of TVT presence within 
the UK, but it is not believed to be enzootic in the UK currently probably due to the high rates of elective 
neutering and low numbers of stray or feral dogs (4,28,36). The co-occurrence of large populations of 
free-roaming dogs, lower GDP per capita and warmer conditions in countries with higher TVT 
prevalence means that it is not possible to draw a certain conclusion on the impact of climatic conditions 
on its spread (4,28). This study showed that while TVT is still rare in the UK, the incidence of diagnosis 
has risen over the period studied. Within the UK, the majority of cases were seen in England although 
this may reflect selection bias as the included laboratories were located in England. It also likely reflects 
that England has both a higher human population, and with it a higher dog population (37). 
 
As would be expected with TVT the majority of lesions in this study were located on the genitalia. As 
this study was conducted with laboratory data rather than the associated clinical record it is impossible 
to know if these were the only lesions present or if multiple were present but only one sampled. This is 
particularly relevant with the case of TVT identified in the lymph node. Having no associated genitalia, 































lesion and the lymph node represents metastasis but unfortunately we had no records of another lesion 
being sampled in this case.  
 
The majority of cases in this study affected dogs that were reported to have been imported. It is easy 
to speculate that most or all of the remaining dogs were also imported. However, in the context of 
determining origin, a limitation of this study is that it relies on information both being included on the 
submission form and then also being transposed into the EPR by the pathologist. Consequently, this 
data cannot absolutely exclude local presence and transmission. Ensuring that the import status and 
country of origin of the patient are included in the medical record and on laboratory request forms would 
facilitate epidemiological monitoring of this and other diseases considered non-enzootic and would 
allow identification of possible local spread with more confidence.  
 
In recent years it has become increasingly popular for UK residents to adopt a dog from a foreign rescue 
organisation rather than buy or adopt a dog locally in the UK (38). It has recently been reported that the 
majority of these rescue dogs are being imported incorrectly under the European Union Pet Travel 
Scheme (PETS; EU regulation 576/2013), which is for the non-commercial movement of animals 
accompanied by their owners (38). Dogs imported for commercial reasons including for a change of 
ownership (sale of puppies or rehoming rescue animals) are covered by the more stringent Balai 
directive (EU regulation 92/65/ECC) (38). The consequence of this approach is that rehomed pets may 
not necessarily have undergone the pre-export health check required by the Balai directive, and the 
opportunity to identify TVT prior to entry into the UK may have been missed. 
 
In the context of the disconnect between import legislation and the facts on the ground it is interesting 
to observe that the incidence of TVT cases has increased in the UK over the past decade. Of the dogs 
with a country of origin noted in the EPR, 80% came from Romania. TVT is known to be enzootic in 
Romania with a prevalence estimate of 5 – 10% in a recent study due to a large roaming dog population 
and low rates of neutering (29). Animal & Plant Health Agency (APHA)  figures show 39,998 dogs were 
imported into the UK from overseas under the Balai directive in 2017 (39), with 15,556 (38%) of these 
originating from Romania (40). There has been an increase in dogs imported from Romania over recent 
years; according to APHA no Romanian dogs were imported into the UK in 2013 (41) while 15,556 were 
imported in 2017 (40). This makes Romania now the most common origin for imported dogs. The high 
number of cases from Romania therefore represents a combination of high prevalence and high import 
rates. Cases imported from other locations with high prevalence likely carry a similar risk of importing 
TVT on a per imported dog basis. In 2017, 287,016 dogs were imported into the UK under PETS (39). 
As the Animal & Plant Health Agency does not record the country of origin for dogs entering under 
PETS (42) and the Balai directive is not always being used as intended, the number of puppies and 
rescue dogs imported into the UK cannot be fully known. This leaves a weakness in the UK’s capability 
to monitor and exclude non-enzootic disease.  
 
The drivers behind the increasing population of dog importation into the UK are likely a combination of 
the relaxation of the PETS travel scheme requirements in 2012 (43), and the passing of a law in 
Romania in 2013 which enables stray dogs to be euthanised if not claimed within 2 weeks (38). This 
led to the formation of several charities in the UK, mostly formed during or after 2014 in response to the 
above law. With the increasing number of dogs being imported (38,40–42), it could be expected that 
some of the risk of import of non-enzootic diseases such as TVT has increased, and this has led to 
growing concern in the veterinary community about the possibility of introduction non-enzootic diseases 
(38,44–51). This is particularly true since the PETS travel scheme was changed in recent years to make 
tick treatment non-mandatory. This step increased the risk that foreign ticks and associated vector-
borne diseases could become established in the UK. Indeed, in recent years, cases of leishmania, 
babesia, and Hepatozoon canis infection have been reported in rehomed imported dogs, and in some 
cases local transmission has been confirmed (46,50,52–55). Given the natural variation in exposure 
risk to particular infectious diseases in different countries it may be prudent to vary monitoring and entry 
requirements dependent upon local risk. 
 
The importation of non-enzootic parasites and diseases has also been seen in multiple other countries 
including (but not limited to) the importation and establishment of Dirofilaria repens (56) and more 
recently Dirofilaria immitis (56,57) into Austria, the importation of leishmaniasis into Canada (58) and 
several non-enzootic (typically northern) European countries (59). Whilst there is no current data on 
TVT being imported into other non-enzootic countries in a similar way, it is certainly possible and careful 
examination of imported dogs is encouraged.  
 
Interestingly the majority of dogs in this study were recorded as neutered. As TVT is largely transmitted 
through coitus (4) and almost all of the lesions were documented to be on the genitalia it seems 
probable that most of these dogs were entire at the time of transmission and neutered shortly before or 
after arrival into the UK. The risk of chains of local transmission in the UK is considered low both 
because most imported dogs are neutered at the time of import or very soon thereafter (38) and 
because the neutering rate in the UK is high reducing the number of local dogs that might engage in 
mating activity. However, local spread cannot be completely excluded as almost a quarter of dogs were 
recorded as entire at time of diagnosis.  
 
This study represents an innovative use of an EPR tumour registry to monitor the changing incidence 
of an unusual canine cancer over a number of years. One consideration when using such data is that 
the diagnostic criteria may change over time. In this context it is worth noting that the proportion of 
cases in which TVT was mentioned, but in which a final diagnosis of TVT was not made broadly tracked 
the total number of recorded cases each year. Consequently, a change in a pathologist’s willingness or 
ability to diagnose TVT is unlikely to explain the increase seen.  
 
The nature of laboratory data means that no information about timing of neutering relative to importation, 
interval between import and presentation to a veterinary surgeon (each of which influence the potential 
for TVT to spread locally), treatment or outcome was present. As SAVSNET does have access to a 
large amount of primary practice data, there is an opportunity to examine these questions in a future 
study.  
 
This study had several limitations. It was retrospective and EPR data has particular limitations. It is 
likely that the incidence numbers in this study are an underestimate, as a reasonable number of cases 
had to be excluded due to a lack of a definitive diagnosis and unfortunately, due to the elapsed time 
the histology blocks were not available for review. Moreover, these pathology reports do not cover all 
submissions made by UK veterinarians. Further, due to the possibility of spontaneous remission we 
cannot be sure that all tumours will have been sampled and not all of those sampled will be submitted 
for pathological assessment. 
 
As the Mann-Kendall test is aimed at identifying presence of monotonic trends, it is not well suited to 
account for seasonal variation in incidence. As we have approached analyses on an annual basis here, 
we do not anticipate this to have impacted our findings, however. We have summarised findings from 
multiple diagnostic laboratories here, though due to the low number of cases observed we have not 
attempted to account for potential clustering effects between laboratories. We therefore cannot 
completely exclude the possibility that variation in diagnostic approach between laboratories might have 
impacted on findings as a result. 
 
There may also be bias in this study as a significant number of cases needed to be excluded due to a 
lack of a definitive diagnosis of TVT (in these cases the diagnosis was most commonly ‘round cell 
tumour’). It is possible that pathologists were less likely to definitively diagnose TVT in non-genital 
lesions, particularly if no travel history was reported by the referring vet.  
 
This study shows that databases of EPRs such as those curated by SAVSNET have significant potential 
as a disease and cancer surveillance tool and therefore represent a useful addition to the veterinary 
cancer surveillance initiatives already in place or being developed (60–62). In this study we identified 
that the incidence of TVT diagnosis is increasing in the UK and it appears to be linked to dog importation 
especially from Romania. Based on these data, veterinary surgeons should carefully examine the 
genitalia of all imported dogs at initial assessment and encourage neutering of these patients either 
prior to entering the country or immediately thereafter to reduce the risk of local spread. Moreover, as 
local transmission cannot be completely excluded, TVT should be on the differential list for any canine 
genital masses identified in the UK.  
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Supplementary Table 1: common non-TVT diagnoses of excluded cases 
Diagnosis Number of cases 
mast cell tumour 6 
plasmacytoma 12 
inflammation 11 
lymphoma 4 
histiocytoma 8 
seminoma 4 
Plasmacytoma/histiocytoma 7 
 
 
